Gyre Therapeutics Inc. (GYRE) support and resistance · rev $53.5M
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
This page maps Gyre Therapeutics Inc. (GYRE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
GYRE currently screens at market cap $589.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GYRE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GYRE quote page for the session range and the stock page for the full model.
Not investment advice.